Gradient Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
3,097
+1
+0% +$342 0.26% 68
2026
Q1
$1.09M Buy
3,096
+7
+0.2% +$2.5K 0.28% 64
2025
Q4
$1.01M Buy
3,089
+3
+0.1% +$952 0.26% 68
2025
Q3
$871K Buy
3,086
+30
+1% +$8.7K 0.23% 73
2025
Q2
$853K Sell
3,056
-38
-1% -$10.8K 0.25% 71
2025
Q1
$964K Sell
3,094
-163
-5% -$48.1K 0.31% 60
2024
Q4
$849K Sell
3,257
-320
-9% -$94.9K 0.27% 65
2024
Q3
$1.15M Buy
3,577
+8
+0.2% +$2.62K 0.38% 56
2024
Q2
$1.11M Buy
3,569
+9
+0.3% +$2.64K 0.4% 54
2024
Q1
$1.01M Sell
3,560
-10
-0.3% -$2.93K 0.37% 60
2023
Q4
$1.03M Sell
3,570
-13
-0.4% -$3.54K 0.39% 57
2023
Q3
$963K Buy
3,583
+87
+2% +$21.7K 0.4% 53
2023
Q2
$776K Sell
3,496
-49
-1% -$11.4K 0.31% 66
2023
Q1
$857K Sell
3,545
-45
-1% -$11K 0.36% 63
2022
Q4
$943K Buy
3,590
+17
+0.5% +$4.56K 0.43% 54
2022
Q3
$805K Buy
3,573
+568
+19% +$138K 0.38% 62
2022
Q2
$731K Buy
3,005
+1,923
+178% +$471K 0.35% 63
2022
Q1
$262K Sell
1,082
-83
-7% -$19.1K 0.11% 105
2021
Q4
$262K Buy
1,165
+5
+0.4% +$1.05K 0.11% 108
2021
Q3
$247K Sell
1,160
-12
-1% -$2.76K 0.11% 106
2021
Q2
$286K Buy
1,172
+23
+2% +$5.66K 0.13% 98
2021
Q1
$286K Buy
1,149
+6
+0.5% +$1.43K 0.15% 95
2020
Q4
$263K Buy
1,143
+66
+6% +$15.2K 0.15% 92
2020
Q3
$274K Sell
1,077
-81
-7% -$20.1K 0.17% 86
2020
Q2
$273K Buy
+1,158
New +$264K 0.18% 84
2020
Q1
Sell
-946
Closed -$228K 89
2019
Q4
$228K Buy
+946
New +$209K 0.16% 87

Other funds holding AMGN

Gradient Capital Advisors's AMGN Position: Q2 2026 in Review

Gradient Capital Advisors increased its Amgen (AMGN) stake by 0.03% in Q2 2026, buying an estimated $342 and bringing the position to 3,097 shares worth $1.12M. The position accounts for 0.26% of the portfolio, ranked #68.

Gradient Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.15M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Gradient Capital Advisors held 3,097 shares of Amgen worth $1.12M as of Q2 2026.
  • Gradient Capital Advisors bought 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.26% of Gradient Capital Advisors's portfolio in Q2 2026, its #68 holding.
  • Gradient Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • Gradient Capital Advisors's Amgen position peaked at $1.15M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Gradient Capital Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.